SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound
REFR 1.730+10.2%Nov 11 3:57 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (2211)7/15/1999 11:28:00 PM
From: BDR  Read Replies (1) of 10293
 
<As you should know by now, the first study on Zicam has already been submitted to the New England Journal of Medicine, what many consider to be the most prestigious medical journal in the world.>

I hate to tell you guys this but, since you seem to bring it up in nearly every one of your posts on the subject of GUMM, submission of an article to the NEJM confers no legitimacy whatsoever on the investigators or study submitted and in this case is not prima facie evidence of the effectiveness of Zicam. Any clown can drop something in the mail to the Journal and say they have "submitted an article to the most prestigious medical journal in the world". Let's wait for the publication when and if that occurs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext